"Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

End User License Agreement (for non-institutional, personal use)

2. LINKING THE EGFR WITH CANCER THERAPUTICS

4. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - LIGANDS OF THE EGFR AS PREDICTORS OF RESPONSE TO ANTI-EGFR THERAPY

5. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - ALTERATIONS IN ERBB RECEPTORS FAMILY MEMBERS

6. Alterations in Non-ErbB Receptor Family Members

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor– Part I: Extracellular Molecules

2. INTRACELLULAR TRAFFICKING OF THE egfr AND RESISTANCE TO ANTI-eGFR Therapy

3. The ras/ref/mek/erk Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

4. The PI3-K Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

5. ANALYSIS OF SEVERAL BIOMARKERS IN COMBINATION AND RESISTANCE TO ANTI-eGFR Therapy

6. The JAK/STAT Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor – Part II: Intracellular Molecules

Chemotherapeutic, Immunologic, and Molecularly Targeted Therapy for the Treatment of Advanced Melanoma

1. THERAPEUTICAL APPROACHES TO CANCER: FROM Chemotherapy to Targeted Therapies

3. THE WARBURG EFFECT: CURRENT PERSPECTIVE

4. CURRENT AND PAST EFFORTS AT TARGETING THE WARBURG EFFECT FOR CANCER THERAPY

Targeting the Warburg Effect for Cancer Therapy: A Long and Winding Road

3. Previous Considerations before Therapy

6. Novel and Emerging Pharmacological Agents

7. Innovative Immunotherapy Strategies for Treatment of FL

Immunotherapy Strategies in Follicular Lymphoma: Antibodies, Vaccines and Cells

Cancer Epigenetics AND Role in Carcinogenesis

Modulation of Metabolism by Epigenetic Dys-regulation

Epigenetic Regulation by the Availability of Co-substrates

Epigenetic Dysregulation Induced by Oncometabolites

Epigenetics and Cancer Cell Metabolism: Cross-talk and Therapeutic Opportunities

Apoptosis Targeting Therapeutics in Clinical Trials

Bentham Science Publishers

"Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives. This book series presents reviews of exciting new bioactive natural products that have huge potential as drugs. Each volume presents comprehensive chapters contributed by eminent scientists. The volumes focus on drug candidates which are in the later stages of drug development and are being evaluated in clinical trials. The series, therefore, highlights the importance of natural products in our lives.
 
The second volume covers the following topics:
 
- A review of recent patents and natural products in clinical trials to treat schistosomiasis
 
- Natural products: the new intervention regimen for metabolic disorders
 
- Fluorine-containing drugs and drug candidates derived from natural products
 
- Natural products for the management of cardiovascular diseases 
 
- Implication of natural compounds for the prevention of ocular diseases"


Natural Products in Clinical Trials: Volume 2

Atta-ur-Rahman

Shazia Anjum

"Frontiers in Clinical Drug Research - Anti-Cancer Agents - Volume 1 should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters in this volume have been written by leading experts from the field.
The contents of this book include new approaches to cancer therapy, treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors, targeting key signaling pathways in pediatric brain tumors, current status of cladribine in lymphoid and myeloid malignancies, natural anti-cancer products and the mechanisms of telomere and telomerase regulation in hematologic malignancies. 
The eBook series is essential to all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the field. The readers will find these reviews valuable and  will certainly trigger further research in the pharmaceutical development of anti-cancer agents."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The fourth volume of this series features reviews that cover a variety of topics including: 
-Strategies to prolong antibiotic life
-Catalytic antibodies for targeting rabies and influenza viruses
-Antiviral therapies for arenaviruses
-The role of steroids in viral infections
-Monoclonal antibody manufacturing processes
-Prevention and eradication of biofilms in medical devices"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. Volume 9 features reviews on these topics: 
 
 
 
·         Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and Beyond
 
·         The Revolutionary Potential of Noble Metal Nanoparticles as Anti-Cancer Agents: State-of-the-Art Applications and Future Perspectives
 
·         Algal Polysaccharides as Promising Anticancer Agents
 
·         Cardiotoxicity Caused by Doxorubicin and Trastuzumab: Current Understanding for Future Preventive Strategies
 
·         Emodin: Anticancer Agent 
 
 
 
Readership
 
Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials.

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9

Frontiers in Natural Product Chemistry is a book series devoted to publishing monographs that highlight important advances in natural product chemistry. The series covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
Volume nine of the series brings together 7 reviews on a variety of natural products and sources along with a chapter on the basics of investigating antioxidant activity.
Propolis and its key chemical constituents: a promising natural product in therapeutic applications
Investigation of the effects of using omega-3 fatty acids on egg quality in functional egg production 
Quercetin, a flavonoid with remarkable anticancer activity 
Swertiamarin for the treatment of metabolic syndrome
Overview of traditional uses, phytochemistry and pharmacology of Peganum harmala l. 
Investigation of measurement methods of antioxidant activity and involved mechanisms
Recent progress on natural and synthetic flavanone and its derivatives
Role of virgin coconut oil as a multiple health promoting function oil

Frontiers in Natural Product Chemistry: Volume 9

Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.


Frontiers in Anti-Cancer Drug Discovery: Volume 2

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
 
 
The eighth volume of this series features reviews that cover the following topics related to the treatment of a variety of CNS disorders, related diseases and basic research:
 
 
 
- Emerging Innovative Therapies of Spinal Muscular Atrophy: Current Knowledge and Perspectives
 
 
 
- Obesity Induced by The Neurological Drugs
 
 
 
- Molecular Mechanism of Nervous System Disorders and Implications for New Therapeutic Targets
 
 
 
- Glioma Imaging and Novel Agents
 
 
 
- Screening Models for Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 8

 Zareen Amtul

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The sixth volume of this series features reviews that cover the following topics:
-Depression, Insomnia and Atypical Antidepressants
-Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates
-Development of A “Theranostic Nano-Bullet” for Tinnitus
-Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection
-Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases 
 "


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

"Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The fifth volume of the series features chapters on the following topics:
-Nutraceuticals and natural food products for cancer treatment
-Pharmacogenomics in Anti-cancer treatment
-Cancer stem cells
-Potassium channel targeting for brain tumor treatment
-Sorafenib in the management of hepatocellular carcinoma
…and more.
 "


Frontiers in Anti-Cancer Drug Discovery: Volume 5

"The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.
Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
This volume brings together 5 reviews on the following topics:
- Retinal angiogenesis
- Effects of brief daily EMF therapy on tumor growths
- Evolution of the role of angiogenesis in cancer treatments over six decades
- Anti-angiogenesis drugs
- Anti-angiogenesis therapy for multiple sclerosis
- Update on the link between angiogenesis and portal hypertension"


Your Cart

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

$ 99.00

Description of Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

Additional Information

About the authors

Atta-ur-Rahman

Natural Products in Clinical Trials: Volume 2

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9

Frontiers in Natural Product Chemistry: Volume 9

Frontiers in Anti-Cancer Drug Discovery: Volume 2

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 8

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

Frontiers in Anti-Cancer Drug Discovery: Volume 5

Anti-Angiogenesis Drug Discovery and Development: Volume 4

Atta-ur-Rahman